Prediction model for early left ventricular systolic dysfunction progression in hypertrophic cardiomyopathy
Frontiers in Cardiovascular Medicine · 12.06.2026 · 13
DOI: 10.3389/fcvm.2026.1764153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.06.2026. Verfasst von Yu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The risk of early left ventricular systolic dysfunction progression (ELVSDP) among patients with hypertrophic cardiomyopathy (HCM) is heterogeneous, and accurate short-and medium-term prediction tools are lacking. This study aimed to develop and validate a predictive model for the risk of ELVSDP in HCM patients at 6, 12, and 18 months.
Methods
A total of 314 HCM patients without ELVSDP at baseline were included and randomly divided into training and validation sets. LASSO-Cox regression was employed to select variables and identify independent predictors, based on which a nomogram and an interactive dynamic prediction tool were constructed. Model performance was evaluated using the concordance index (C-index), time-dependent receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Risk stratification was assessed using the Kaplan–Meier method.
Results
Age [hazard ratio (HR) = 1.17], smoking history (HR = 2.79), B-type natriuretic peptide (BNP) level (HR = 1.002), and left ventricular outflow tract obstruction (HR = 2.24) were independent predictors of ELVSDP. The model demonstrated strong performance in both the training and validation sets. The time-dependent area under the curve (AUC) exceeded 0.88 at 6, 12, and 18 months, with C-indices of 0.94 and 0.93, respectively. Bootstrap validation confirmed model stability. Calibration curves showed good agreement between predicted and observed outcomes, and DCA indicated a net clinical benefit. The incidence of ELVSDP was significantly higher in the high-risk group compared to the low-risk group ( P < 0.0001).
Conclusion
The nomogram developed in this study accurately predicts short-term ELVSDP risk in HCM patients, facilitating early risk stratification and individualized management. Clinical Trial Registration This study was registered at the Chinese Clinical Trial Registry http://www.chictr.org.cn/ , registration number ChiCTR2500106648 [Registration Date: 2025-07-28].
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Gastrointestinal Surgery, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
Zitieren
APA
Li, Y., Duan, Z., Li, J., Cheng, B., Ai, F., & Chen, Z. (2026). Prediction model for early left ventricular systolic dysfunction progression in hypertrophic cardiomyopathy. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1764153
Vancouver
Li Y, Duan Z, Li J, Cheng B, Ai F, Chen Z. Prediction model for early left ventricular systolic dysfunction progression in hypertrophic cardiomyopathy. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1764153
BibTeX
@article{Li2026,
author = {Li, Yu and Duan, Ziqi and Li, Jinlei and Cheng, Bingxin and Ai, Fen and Chen, Zhen},
title = {Prediction model for early left ventricular systolic dysfunction progression in hypertrophic cardiomyopathy},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1764153}
}
EUVIMED